Amethopterin (methotrexate) in connective tissue disease-psoriasis and polyarthritis.
作者信息
Kersley G D
出版信息
Ann Rheum Dis. 1968 Jan;27(1):64-6. doi: 10.1136/ard.27.1.64.
Abstract
摘要
相似文献
1
Amethopterin (methotrexate) in connective tissue disease-psoriasis and polyarthritis.
Ann Rheum Dis. 1968 Jan;27(1):64-6. doi: 10.1136/ard.27.1.64.
2
The use of methotrexate in steroid-resistant systemic lupus erythematosus.
Arthritis Rheum. 1988 May;31(5):612-5. doi: 10.1002/art.1780310505.
3
Cutaneous ulceration with methotrexate.
Prescrire Int. 2003 Apr;12(64):59-60.
4
Severe oral ulceration in a patient taking low-dose methotrexate for rheumatoid arthritis.
Compend Contin Educ Dent (Lawrenceville). 1986 Jun;7(6):430-3.
5
[Methotrexate in rheumatic practice].
Ann Med Interne (Paris). 1989;140(3):192-6.
6
Cytotoxic drugs: their clinical application to the rheumatic diseases.
Semin Arthritis Rheum. 1986 May;15(4):231-54. doi: 10.1016/0049-0172(86)90020-x.
7
[Comparative study of the effect of the antimetabolic agent methotrexate in psoriasis, psoriatic arthropathy and rheumatoid arthritis].
Verh Dtsch Ges Rheumatol. 1969;1:383-7.
8
The current status of methotrexate use in rheumatic diseases.
Bull Rheum Dis. 1986;36(4):1-10.
9
Methotrexate in psoriasis.
Br J Dermatol. 1968 Aug;80(8):534-9. doi: 10.1111/j.1365-2133.1968.tb12344.x.
10
Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Dig Dis Sci. 1985 Feb;30(2):104-9. doi: 10.1007/BF01308193.
引用本文的文献
1
Marine-derived microbes and molecules for drug discovery.
Inflamm Regen. 2022 Jun 3;42(1):18. doi: 10.1186/s41232-022-00207-9.
2
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics.
Front Pharmacol. 2017 Jul 12;8:460. doi: 10.3389/fphar.2017.00460. eCollection 2017.
3
Ciclamilast ameliorates adjuvant-induced arthritis in a rat model.
Biomed Res Int. 2015;2015:786104. doi: 10.1155/2015/786104. Epub 2015 Apr 27.
4
Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis.
Clin Drug Investig. 2006;26(2):55-62. doi: 10.2165/00044011-200626020-00001.
5
Antirheumatic drugs: clinical pharmacology and therapeutic use.
Drugs. 1980 Dec;20(6):453-84. doi: 10.2165/00003495-198020060-00002.
6
Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.
Ann Rheum Dis. 1988 Aug;47(8):654-9. doi: 10.1136/ard.47.8.654.
7
Treatment of arthritis associated with psoriasis.
Br Med J. 1978 Feb 4;1(6108):262-3. doi: 10.1136/bmj.1.6108.262.
本文引用的文献
1
Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.
Am J Med Sci. 1951 Feb;221(2):176-82.
2
FOLIC-ACID ANTAGONISTS IN TREATMENT OF PSORIASIS.
Br Med J. 1965 Jul 17;2(5454):156. doi: 10.1136/bmj.2.5454.156.
3
THE TREATMENT OF PSORIASIS WITH FOLIC ACID ANTAGONISTS.
Br J Dermatol. 1964 Dec;76:555-64. doi: 10.1111/j.1365-2133.1964.tb15506.x.
4
AMINOPTERIN FOR PSORIASIS. A DECADE'S OBSERVATION.
Arch Dermatol. 1964 Dec;90:544-52. doi: 10.1001/archderm.1964.01600060010002.
5
Methotrexate in psoriasis.
Lancet. 1967 May 27;1(7500):1165. doi: 10.1016/s0140-6736(67)91751-5.
Zotero 插件